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Abstract
Background: Tobacco use continues to be a global public health problem. Helping patients to quit
is part of the preventive role of all health professionals. There is now increasing interest in the role
that the dental team can play in helping their patients to quit smoking. The aim of this study was to
determine the feasibility of undertaking a randomised controlled smoking cessation intervention,
utilising dental hygienists to deliver tobacco cessation advice to a cohort of periodontal patients.
Methods: One hundred and eighteen patients who attended consultant clinics in an outpatient
dental hospital department (Periodontology) were recruited into a trial. Data were available for
116 participants, 59 intervention and 57 control, and were analysed on an intention-to-treat basis.
The intervention group received smoking cessation advice based on the 5As (ask, advise, assess,
assist, arrange follow-up) and were offered nicotine replacement therapy (NRT), whereas the
control group received 'usual care'. Outcome measures included self-reported smoking cessation,
verified by salivary cotinine measurement and CO measurements. Self-reported measures in those
trial participants who did not quit included number and length of quit attempts and reduction in
smoking.
Results: At 3 months, 9/59 (15%) of the intervention group had quit compared to 5/57 (9%) of the
controls. At 6 months, 6/59 (10%) of the intervention group quit compared to 3/57 (5%) of the
controls. At one year, there were 4/59 (7%) intervention quitters, compared to 2/59 (4%) control
quitters. In participants who described themselves as smokers, at 3 and 6 months, a statistically
higher percentage of intervention participants reported that they had had a quit attempt of at least
one week in the preceding 3 months (37% and 47%, for the intervention group respectively,
compared with 18% and 16% for the control group).
Conclusion: This study has shown the potential that trained dental hygienists could have in
delivering smoking cessation advice. While success may be modest, public health gain would
indicate that the dental team should participate in this activity. However, to add to the knowledge-
base, a multi-centred randomised controlled trial, utilising biochemical verification would be
required to be undertaken.
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Background
Whilst the general health concerns of tobacco use are well
known, the detrimental effect of tobacco use on the
mouth is less often acknowledged. Oral problems can
vary from aesthetic concerns, such as staining of the teeth
and halitosis, through to periodontal disease, and more
serious conditions such as potentially malignant lesions
and oral cancer. There is a well-demonstrated dose-
response relationship between tobacco use and risk of
developing oral cancer, with the risk increasing signifi-
cantly with the number of cigarettes smoked and the dura-
tion of smoking [1]. Individuals who smoke and do not
drink alcohol have a two to four-fold increased risk of
developing oral cancer [2,3]. Globally, oral cancer is the
sixth most common malignant tumour for both genders
[4].
The strong links between cigarette smoking and periodon-
tal disease are also well established, with smokers being
approximately three times more likely than non-smokers
to have periodontitis [5]. The relationship is even stronger
among those more severely affected by the disease. Con-
sequently, smokers tend to have more bone loss and fewer
teeth than non-smokers [6].
While the oral problems caused by smoking legitimise the
involvement of dental team members in the provision of
tobacco cessation advice, it is also important that dental
professionals take a holistic approach to health promo-
tion, and provision of smoking cessation advice is an
example of this. There is now an increasing interest in the
role that the dental team can play in helping their patients
to quit smoking.
The Cochrane Library has a number of tobacco-related
reviews addressing the issue of physician and nurse-deliv-
ered smoking cessation advice [7,8]. The evidence relating
to tobacco cessation and the dental team has recently
been published; however, of the six studies included in
the review, five are associated only with smokeless
tobacco [9]. The review concludes that, currently, insuffi-
cient evidence exists to make recommendations about the
effectiveness of tobacco cessation interventions in a dental
setting for cigarette smokers. Of the very limited number
of studies in the UK to date, none have utilised a ran-
domised controlled trial design with biochemical verifica-
tion of cessation. The aim, therefore, of this trial was to
examine the feasibility of undertaking an RCT smoking
cessation intervention, delivered by trained dental hygien-
ists, in a cohort of periodontal patients attending an out-
patient dental hospital department.
Methods
Having obtained ethical approval from the local Dental
Ethics committee, participants were recruited from a
cohort of new patients (smoking >10 cigarettes per day)
attending Periodontology consultant clinics at a dental
hospital, and referred for treatment to the staff dental
hygienists. As part of normal professional practice, all new
patients received information on the role that tobacco
plays in periodontal disease and 'very brief' advice to quit
smoking by the examining consultant. Recruitment was
by the consultant, who explained the nature of the trial,
and gave the patient an information sheet. Informed con-
sent was obtained from the patients prior to participation
in the trial. It was made explicit that patients would not
necessarily be allocated to receive further advice and help,
in addition to their periodontal treatment. Exclusion cri-
teria included those aged below 18 years, those already in
receipt of nicotine replacement therapy or currently
undergoing smoking cessation therapy or patients with
complex medical histories. This study encompassed only
cigarette smokers, as it is this group of tobacco users who
constitute the vast majority of patients attending for peri-
odontal treatment in this dental hospital setting.
At baseline, socio-demographic information was collected
from the participants as well as information on nicotine
dependence, as measured by the Fagerstrom Test for Nic-
otine Dependence [10]. Motivation to quit was also deter-
mined using a questionnaire based on 'Stage of Change'
[11]. Information on lifetime exposure, as measured by
pack-years, was also collected, as was participants' current
exposure to smoke at home and work.
The baseline level of smoking was measured by the use of
unstimulated salivary cotinine (COT) and level of carbon
monoxide (CO) in an exhaled air sample. Cotinine is
widely accepted as the most accurate means of measuring
tobacco exposure [12]. Cotinine levels were measured
using ELISA immunoassay kits (Cozart UK). The detailed
methodology for unstimulated salivary sample collection
has been published previously [13]. However, carbon
monoxide monitoring is the most widely used method of
measuring cigarette consumption, and can be useful in
determining the smoking status of a patient who is taking
NRT. In addition, CO levels can also be used as a motiva-
tional tool. The CO monitors used were picoSmokelysers
(Bedfont Scientific, UK).
The randomisation process was set up by the project stat-
istician (SM) and was implemented independently from
the recruitment process. After a patient was recruited into
the study by a consultant, the patient's name was tran-
scribed into a log book, which contained sequential
patient log numbers and against each, the allocated hygi-
enist. Having allocated the patient to a hygienist, the
patient was then allocated to either intervention or con-
trol group using the minimisation method (with weighted
randomisation) [14,15]. The allocation to the group wasBMC Oral Health 2007, 7:5 http://www.biomedcentral.com/1472-6831/7/5
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balanced by sex, age (<34, 35–44, 45–54 >55), level of
deprivation (as measured by Carstairs Deprivation Index,
low/moderate/high DEPCAT [16]), level of nicotine
dependence (<6, ≥6) and modified 'Stage of Change' (not
interested, concerned about their smoking and wanting to
stop).
Those participants allocated to the intervention group
received, in addition to their clinical care, smoking cessa-
tion advice delivered by one of three staff dental hygien-
ists. These dental hygienists had undergone training,
including smoking cessation sessions (1 day equivalent,
which covered epidemiology of tobacco use, nicotine
dependence, basic smoking cessation skills, supporting
the smoker), and training in NRT (1/2 day, which covered
nicotine withdrawal, use of NRT products, relevant clini-
cal guidelines) and trial methodology (1/2 day, which
covered use of questionnaires in data collection, 5As
methodology, salivary and CO sampling).
The model of advice used was the 5As [17]. This structured
advice is based upon ask/advise/assess/assist/arrange
follow-up for the patient and has been used in a number
of settings, such as general medical practice [18]. A cus-
tomised protocol with particular emphasis on oral health
aspects was developed for use by the dental hygienists
[19]. As part of the 'assist' phase, the intervention partici-
pants, if they so wished, received free nicotine replace-
ment therapy (NRT) in the form of patches or gum, as part
of their treatment plan. This was funded by the local NHS
Smoking Cessation Services (Smoking Concerns, Glas-
gow, UK).
Follow-up information, at 3 and 6 months, was collected
via self-completed questionnaires. At one year, data were
collected by telephone by a research hygienist.
The outcome of quitting (point prevalence) was measured
at 3, 6 and 12 months, with repeated point prevalence
measures reported at 6 and 12 months. The measures used
included self-report as well as CO and cotinine (COT)
measurements. Biochemical verification of smoking sta-
tus of all participants, whether smokers or non-smokers
was undertaken at 3 and 6 months. At 12 months, if a par-
ticipant reported that they had quit, they were asked to
return a sample of saliva by post for verification of smok-
ing status. No cotinine samples were collected from smok-
ers at 12 months. A cut-off of 20 ng/ml cotinine was used
to determine a smoker from a non-smoker, whereas a cut-
off of 8 ppm was used for the CO monitoring. Informa-
tion was also collected on use of NRT at the time of data
collection.
For those participants who considered themselves smok-
ers at 3 and 6 months, information was collected on the
number and length of any quit attempts and current
smoking behaviours, in addition to CO and COT samples.
The number of visits by the study participants, to the den-
tal hygienists, during the study period was also collected.
Information from the questionnaires and biochemical
information regarding CO and COT levels was entered
into data entry forms designed in Microsoft Access, which
was then used to manage the data. Data were then
exported for statistical analysis into Minitab (version 14)
and StatXact (version 4).
Statistical analysis compared the intervention and control
groups in terms of baseline information, and outcomes at
3 and 6 months. When comparing the two groups, contin-
uous normally distributed data were summarised by
means and standard deviation and analysed using the
two-sample t-test and confidence intervals. Data which
were numerical but not normally-distributed were sum-
marised by medians and inter-quartile ranges and groups
compared using the Mann-Whitney test and confidence
intervals. When comparing groups in terms of categorical
variables, tables were produced to summarise the data,
which were analysed using chi-squared tests. Outcomes,
which were binary variables, were compared between
groups using tests of equal proportions and confidence
intervals for the difference between intervention and con-
trol groups. Results of the statistical tests were considered
to be significant if the p-value was less than 0.05 and cor-
respondingly if the confidence interval for the average dif-
ference between groups did not contain zero.
Results
At baseline, 118 participants were recruited. One subject
died and one subject withdrew consent after completing
the baseline questionnaire but prior to attending for any
study visits. Therefore data were available for 116 subjects,
59 intervention and 57 control. Figure 1 shows the flow of
participants through the trial at the various timepoints.
Baseline characteristics
There was a predominance of women recruited to the trial
(71%). With respect to the baseline characteristics (Table
1), there was no significant difference between interven-
tion and control groups with respect to gender or socio-
economic status as measured by DEPCAT. However, there
was a statistically significant difference between groups in
terms of the mean age of the participants.
There was no statistically significant difference between
intervention and control groups with respect to any of the
smoking behaviours or nicotine dependence variables,
nor was there a significant association between the allo-
cated group and motivation to quit as measured by 'StageBMC Oral Health 2007, 7:5 http://www.biomedcentral.com/1472-6831/7/5
Page 4 of 9
(page number not for citation purposes)
of Change'. With regards to those not interested in quit-
ting, 13% of all trial participants indicated that they were
not interested in stopping smoking at the start of the
study.
There was no significant difference between the mean
baseline biochemical values in the two groups (Table 1).
Three month outcomes
Data were collected from 102 of 116 participants (87.9%)
at this timepoint.
Table 2 outlines the numbers of participants followed up,
in addition to further information on quitters as deter-
mined by self-report, CO and COT levels, for the two
groups.
In summary, with respect to all trial participants, the 9
intervention and 5 control participants determined as
having quit smoking, represented quit rates of 15.3% and
8.8% respectively. However, the difference between inter-
vention and control groups, in terms of the proportion of
participants classified as quitters, did not reach statistical
significance (p = 0.449, 95% CI (I-C) = (-8.4, 25.6)%).
In relation to NRT usage, 6/9 quitters in the intervention
group had used NRT supplied as part of the study, with 3
using no NRT. In the control group, 1 individual had used
Zyban, a further 3 had obtained NRT from another source,
such as the general medical practitioner, and one control
participant reported that they had not used any form of
biochemical support.
For those participants still smoking, a number of out-
comes were collected with respect to any changes in smok-
ing and quitting behaviours (Table 3). With regards to
quit attempts, at 3 months, there was a statistically signif-
icantly higher proportion of participants who reported a
sustained quit attempt of one week or longer in the inter-
vention group (16/43; 37%) compared to the control
group (8/44; 18%) (p-value = 0.043, 95% CI (I-C) = (1,
37)%). There was also a statistically significantly higher
proportion of participants who reported reducing their
smoking behaviour in the intervention group (35/43;
81%) compared to the control group (20/44; 45%) (p-
value < 0.001, 95% CI (I-C) = (17, 55)%). With regards to
other self-reported potential changes, such as inhaling
less, or smoking less of a cigarette, there was no statisti-
cally significant difference between the groups at this
timepoint.
The median number of visits to the staff hygienists
between baseline and three months was 4.5 visits (range
1–6) for quitters, with the median number of visits for
trial participants categorised as smokers at 3 months
being 4.0 (range 2–7).
Six month outcomes
With respect to the 6 month outcomes, information was
collected from 71/116 (61.2%) of the participants.
Of the intervention group, 6 self-reported that they had
quit, and CO measurements confirmed this in all cases
(Table 2). With respect to cotinine verification, there was
evidence that one participant was using NRT, with 5 hav-
ing cotinine levels below 20 ng/ml. In the control group,
3 self-reported having quit and this was confirmed by CO
in 2 of the cases (there was one missing CO value). Coti-
nine levels confirmed cessation for 2 of the participants,
with one person reported as taking NRT. This translates to
6/59 quitters (10.2%) in the intervention group, com-
pared to 3/57 (5.3%) in the control group. However, there
was no statistically significant difference between the
intervention and control groups in terms of the propor-
Movement of Participants Through the Study Figure 1
Movement of Participants Through the Study.
118 current smokers
attending outpatient clinic
(Dental Hospital)
completed baseline
questionnaire
N = 59
Intervention
N = 59
Control
Received allocated
intervention (59)
& standard care
Received standard care
(1 died, 1 withdrew
consent for further
participation in study)
3 month follow-up
N = 52
Lost to follow-up = 7
Validated quitters = 9 (15.3%)
3 month follow-up
N = 57
Lost to follow-up = 7
Validated quitters = 5 (8.8%)
Randomised
to group
6 month follow-up
N = 36
Lost to follow-up = 23
Validated quitters = 6 (10.2%)
6 month follow-up
N = 35
Lost to follow-up = 22
Validated quitters = 3 (5.3%)
1 year follow-up
N = 33
Lost to follow-up = 26
Validated quitters = 4 (6.8%)
1 year follow-up
N = 23
Lost to follow-up = 34
Validated quitters = 2 (3.5%)BMC Oral Health 2007, 7:5 http://www.biomedcentral.com/1472-6831/7/5
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tion of participants classified as having quit (p-value =
0.530, 95% CI (I-C) =(-8.5, 23.6)%). With regards to
repeated point prevalence, there were 5/59 (8.5%) in the
intervention group, compared to 3/57 (5.3%) in the con-
trol group (p-value = 0.671, 95% CI (I-C) =(-9.9, 21.8)%).
Characteristics of the 6 month quitters indicated that all
were female, with 7 out of 9 coming from the more afflu-
ent DEPCAT 1–4 categories.
With regards to NRT use, all successful 6-month quitters
used some form of biochemical support at some point in
their quit attempt. The intervention participants had used
patches supplied as part of the study, one control had
used Zyban and two other control individuals had used
other manufacturers brands of patch.
As at 3 months, for those participants still smoking, a
number of outcomes were collected with respect to any
changes in smoking and quitting behaviours (Table 4). At
6 months, with regards to quit attempts, a greater propor-
tion in the intervention group reported a quit attempt of
1 week or more (14/30; 47%), compared to the control
group (5/32; 16%). This result was of statistical signifi-
cance (p-value = 0.018, 95% CI (I-C) = (6, 56)%). There
was also a statistically greater proportion of participants in
the intervention group who reported any quit attempt in
the last three months (25/30; 83%) compared to the con-
trol group (18/32; 56%) (p-value = 0.033, 95% CI (I-C) =
(3, 53)%). There were no statistically significant differ-
ences between the groups, at 6 months, in terms of any
other changes in smoking behaviour.
The median number of visits for quitters at 6 months was
7 (range 6–8), while the median number of visits for trial
Table 2: Breakdown of number of participants followed-up and quitters at 3 and6 months and 1 year, as defined by self-report, carbon 
monoxide and salivary cotinine
3 months 6 months 1 Year
Intervention
 (n = 59)
Control 
(n = 57)
Intervention
 (n = 59)
Control
 (n = 57)
Intervention
 (n = 59)
Control
 (n = 57)
Number (%) followed up 52 (88.1%) 50 (87.7%) 36 (61.0%) 35 (61.4%) 33 (55.9%) 23 (40.4%)
Number (%) of self-reported quitters 9/59 (15.3%) 5/57 (8.8%) 6/59 (10.2%) 3/57 (5.3%) 7/59 (11.9%) 3/57 (5.3%)
Number (%) of quitters by Carbon Monoxide 9/59 (15.3%) 4/57 (7.0%) (1 
missing value)
6/59 (10.2%) 2/57 (3.5%) (1 
missing value)
na na
Number (%) of quitters by Cotinine 6 + 1* + 2** (15.3%) 2 + 2* + 1** (8.8%) 5 + 1* (10.2%) 2 + 1* (5.3%) 4 + 1† + 2‡ 2 + 1†
Quitters 9/59 (15.3%) 5/57 (8.8%) 6/59 (10.2%) 3/57 (5.3%) 4/59 (6.8%) 2/57 (3.5%)
Carbon monoxide (CO) quitter: <8 ppm, Cotinine (COT) quitter: <20 ng/ml
*COT >20 ng/ml but evidence of NRT use at time of sampling
**COT >20 ng/ml but CO <<8 ppm
†self reported quitter but cotinine level above cut-offs (373 ng/ml and 385 ng/ml)
‡self reported quitter but did not return biochemical sample
Table 1: Baseline individual variables at enrolment of periodontal patients
Variable Intervention (n = 59) Control (n = 57) Comparison of I and C groups
Demographics
Mean (SD) Age (years) 39.9 (8.0) 43.5 (8.0) 95% CI (C-I) = (0.6, 6.5)
Gender (female) 45/59 (76%) 37/57 (65%) χ2 = 1.805 df = 1 p = 0.179
Deprivation Category (5–7 i.e. more deprived) 28/59 (47%) 29/57 (51%) χ2 = 0.136 df = 1 p = 0.713
Nicotine Dependence and Exposure
Median (IQ) number of cigarettes/day 20 (15–40) 20 (15–25) 95% CI (C-I) = (-1,5)
Mean (SD) number of years smoked 22.5 (7.9) 25.2 (8.2) 95% CI (C-I) = (-0.3, 5.6)
Mean (SD) pack years 21.5 (12.5) 24.8 (12.1) 95% CI (C-I) =(-1.3, 8.0)
Median (IQ) Heaviness of Smoking Index (HSI) 3.0 (3.0–4.0) 4.0 (3.0–4.0) 95% CI (C-I) = (0.0, 1.0)
Median (IQ) Fagerstrom Test for Nicotine Dependence (FTND) 5.0 (3–6) 5.0 (3–7) 95% CI (C-I) = (0.0, 1.0)
Exposure to smoke at home 32/59 (56%) 27/57 (52%) χ2 = 1.061 df = 2 p = 0.628
Intention to quit
Motivation to quit/'Stage of Change'
• Precontemplator 6/59 (10%) 9/57 (16%) χ2 = 1.076 df = 2 p = 0.584
• Contemplator 26/59 (44%) 26/57 (46%)
• Preparation 27/59 (46%) 22/57 (38%)
Biochemical Measures
Mean (SD) cotinine level (ng/ml) 231.9 (95.0) 243.3 (104.3) 95% CI (C-I) = (-25.3, 48.2)
Mean (SD) CO level (ppm) 22.0 (8.8) 20.8 (9.1) 95% CI (C-I) = (-2.2, 4.5)BMC Oral Health 2007, 7:5 http://www.biomedcentral.com/1472-6831/7/5
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participants categorised as smokers at 6 months was 6
(range 1–8).
One year outcomes
At one year information was gathered from 48.3% of the
participants, 55.9% (33/59) in the intervention group,
and 40.4% (23/57) in the control group (Table 2). There
were 7 (11.9%) self-reported quitters in the intervention
group, with 3 (5.3%) in the control group. Saliva samples
for cotinine analysis were received from eight out of ten
self-reported quitters. Both individuals who did not return
their samples were from the intervention group. In addi-
tion, two samples (one from each group) had levels far
above the cut-off (373 and 385 ng/ml) and there were no
participants who reported using NRT. Therefore the bio-
chemically validated quit rate at one year was 4/59 (6.8%)
for the intervention group and 2/57 (3.5%) for the con-
trol group. With respect to repeated point prevalence
measures at one year, there were 3/59 (5.1%) of partici-
pants in the intervention group and 2/57 (3.5%) in the
control group who were also quitters at both 3 and 6
months.
Discussion
This study aimed to determine the feasibility of undertak-
ing a smoking cessation trial utilising trained dental hygi-
enists within a secondary care setting. There is currently
little valid research in this area, utilising an RCT design
and with the quit rates biochemically validated. The aim
was to develop a study protocol utilising an RCT design,
with a detailed system of randomisation and testing the
5As model of smoking cessation in a dental setting. In
addition, NRT advice and products were delivered by the
dental hygienists at a time when the use of such products
in hospital periodontal dental practice was not usual.
Stringent use of biochemical measures, both cotinine and
CO, were a feature of this trial. While cotinine is consid-
ered the most accurate method of measuring tobacco
exposure, CO is the most widespread means of determin-
ing smoking status [20].
With respect to elements of the study protocol, it was pos-
sible to recruit patients into a clinical trial with an RCT
design. The randomisation, though time consuming to
carry out, did produce similar groups with the exception
Table 4: Self-reported quit attempts (number and duration) and changes insmoking behaviours of participants at 6 months
Number (%) of Participants
Quit attempts: All n = 62 Intervention n = 30 Control n = 32 p-value 95% CI (I-C)
In last 3 months 43 (69%) 25 (83%) 18 (56%) 0.033 (3, 53)%
2 or more 22 (35%) 13 (43%) 9 (28%) 0.260 (-11, 41)%
24 hours or more 33 (53%) 18 (60%) 15 (47%) 0.330 (-13, 40)%
1 week or more 19 (31%) 14 (47%) 5 (16%) 0.018 (6, 56)%
Other Changes:
Delay Smoking for >5 min 54 (87%) 28 (93%) 26 (81%) 0.380 (-10, 38)%
Inhale Less of a Cigarette 12 (19%) 7 (23%) 5 (16%) 0.546 (-17, 35)%
Smoke Less of a Cigarette 27 (44%) 14 (47%) 13 (41%) 0.688 (-20, 34)%
Changed to Low Tar Cigarettes 21 (34%) 12 (40%) 9 (28%) 0.386 (-14, 38)%
Reduced Number of Cigarettes per Day 38 (61%) 20 (67%) 18 (56%) 0.430 (-14, 38)%
Table 3: Self-reported quit attempts (number and duration) and changes insmoking behaviours of participants at 3 months
Number (%) of Participants
Quit attempts: All n = 87 Intervention n = 43 Control n = 44 p-value 95% CI (I-C)
In last 3 months 43 (49%) 24 (56%) 19 (43%) 0.235 (-8, 34)%
2 or more 27 (31%) 14 (33%) 13 (30%) 0.761 (-16, 23)%
24 hours or more* 40 (47%) 23 (55%) 17 (39%) 0.129 (-5, 37)%
1 week or more 24 (28%) 16 (37%) 8 (18%) 0.043 (1, 37)%
Other changes:
Delay Smoking for >5 min 78 (90%) 40 (93%) 38 (86%) 0.303 (-6, 19)%
Inhale Less of a Cigarette 21 (24%) 12 (28%) 9 (18%) 0.415 (-11, 25)%
Smoke Less of a Cigarette 44 (51%) 24 (56%) 20 (45%) 0.331 (-11, 31)%
Changed to Low Tar Cigarettes 19 (22%) 12 (28%) 7 (16%) 0.172 (-5, 29)%
Reduced Number of Cigarettes per day 55 (63%) 35 (81%) 20 (45%) <0.001 (17, 55)%BMC Oral Health 2007, 7:5 http://www.biomedcentral.com/1472-6831/7/5
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of age. In this trial, the system of randomisation used was by
practitioner, with each study hygienist delivering both inter-
vention and control care. This may have led to some contam-
ination, resulting in a higher than expected quit rate in the
control group. In a definitive multi-centre study, a cleaner
study design would be to randomise by practice, rather than
practitioner. A structured protocol utilising the 5As and
emphasising the oral health aspects as well as general health
benefits, was developed and completed at each visit the
patient received smoking cessation advice. The dental hygi-
enists were trained in the use of NRT, and discussed this with
the patients who wished to use it during their quit attempt.
There is debate over the most appropriate timeframes to
use for follow-up in smoking cessation trials [21].
Researchers are in agreement that the longer the follow-
up, the more valid the findings. However, it is also known
that the longer the follow-up, the higher the number of
participants lost to follow-up. The Cochrane Review of
tobacco cessation in a dental setting requires a minimum
follow-up of 6 months, and the Society for Nicotine and
Tobacco Research recommends 6 and 12 month follow-ups
[21]. Many studies report a shorter time period of 1 or 3
months, which gives an indication of earlier outcomes
including a higher follow-up and success rate. In this trial,
while it was possible to collect data from 88% of partici-
pants at 3 months, this had fallen to 61% by 6 months
and 48% at one year. However, as is standard practice in
tobacco cessation work, all patients lost to follow-up can
be included in the analysis, by assuming that they are still
smoking. Participants by the later time periods had often
completed their periodontal treatment and were more dif-
ficult to trace, and would often decline to return for fol-
low-up visits, when no treatment was required.
While the number of participants recruited to the trial was
relatively small, this was of a similar size to other smoking
cessation trials in a dental setting [22-24]. With regards to
the cessation rates, the shorter the length of follow-up, the
higher the number of participants who stop smoking, and
the results of this study reflect this, with a 15.3% quit rate
in the intervention group at 3 months, compared to
10.2% at 6 months. The quit rate at one-year in the inter-
vention group was 7.0%. Point prevalence quit rates in the
intervention group were approximately twice those in the
control group, at each of the three follow-up time points
(3, 6 and 12 months). Repeated point prevalence meas-
ures showed smaller differences between intervention and
control groups at 6 and 12 months. The differences in
point prevalence quit rates, however, between the inter-
vention and control groups in this pilot study were not
statistically significant. This was, in part, a result of the rel-
atively small number of participants recruited and clearly
a larger, statistically powered, RCT study is required to
confirm the potential effect of the intervention shown
here. Based on the 6-month results (point prevalence)
from this preliminary study, a simple sample size calcula-
tion showed that to declare statistical significance of a 5%
difference (with 10% cessation rate in the intervention
group and 5% cessation rate in the control group), with
80% power, would require approximately 465 partici-
pants per group to be followed up at 6 months. Audit fig-
ures for the department used in this pilot study suggest
that there is a throughput of approximately 275 suitable
patients per year, and thus it would appear that any
future/subsequent RCT would need to be of multi-centre
design (with appropriate sample size calculations).
The median number of visits at 6 months was 6–7, higher
than one would expect in other dental settings, such as in
primary care. Therefore, a success rate of 10% (point prev-
alence) is modest, verging on disappointing, for the rela-
tive amount of time invested. However, half of the
participants recruited were from the more deprived areas,
as measured by DEPCAT, and it is widely known that the
success rate is lower with individuals from more deprived
backgrounds [25].
Amongst the group of trial participants who continued to
smoke, regarding the outcome of increase in number of
quit attempts, at both 3 and 6 month follow-up time-
points there was a statistically higher percentage of indi-
viduals in the intervention group compared to the control
group who reported that they had made a quit attempt of
at least one week. This was a positive behaviour change on
the part of the participants. It has been reported that hav-
ing successful quit attempts, albeit if the patient relapses,
helps increase patient efficacy, increasing the likelihood
that the patient will be successful in the future [26,27].
With regards to reduction in daily number of cigarettes at
3 months, 81% of the intervention group reported reduc-
ing, compared to 45% of the control group (p < 0.001).
Currently there is increasing interest in harm reduction
strategies such as reduction in daily number of cigarettes,
as a precursor to quitting.
Given the lack of good quality research in this area, there
is a paucity of studies against which to compare the results
of this study. The highest level of research evidence is that
of systematic reviews. One review of different types of
smoking cessation interventions such as 'brief' opportun-
istic advice from a physician, or the use of different forms
of nicotine replacement therapy, utilises evidence from
the Cochrane Library [28]. The intervention most similar
in type to the trial reported in this paper, is that of an
intervention using NRT and intensive support (defined as
an initial session of more than 30 min). The success rate
of this type of intervention is quoted as 6% of participants
being quitters at 6 months [28]. In this case, success is
measured by reporting the difference between the inter-BMC Oral Health 2007, 7:5 http://www.biomedcentral.com/1472-6831/7/5
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vention and 'usual care'/control groups. This current trial,
using trained dental hygienists to deliver the advice,
showed a 5% difference between the quit rates of the
intervention and control groups at 6 months which is sim-
ilar to that of other health professionals [28].
Within the UK, there has been limited tobacco cessation
work undertaken in a dental setting. This intervention was
delivered in a specialised secondary care setting and its
findings may not be generalisable to primary care. A con-
temporaneous study, undertaken in Newcastle, utilised
dental hygienists to give advice in a hospital periodontal
department. The Newcastle study yielded a success rate of
29% at 6 months, falling to 25% at one year. This trial had
as its main outcome observing the effect of quitting on the
periodontium [29]. There has been one trial utilising both
dentists and hygienists in primary care, and this resulted
in a quit rate of 11% at 9 months [22]. However neither
of these trials was of an RCT design. Randomised control-
led trials are widely considered to be the most reliable
form of scientific evidence because it is the best-known
design for the elimination of bias that regularly compro-
mises the validity of research [30].
The dearth of high quality evidence may also be an indi-
cator of how time-consuming tobacco cessation work is to
undertake, with large effort expended for relatively little
'gain'. As much effort can be expended undertaking
patient follow-ups, as is spent on delivering the cessation
advice in the first place, and with relatively small numbers
of individuals quitting. However, while gains in the form
of quitters may be small with regards to absolute num-
bers, from a public health perspective, benefit may be
large both on a population and individual health gain
basis [31].
Another model of care for those patients highly addicted
to nicotine, though motivated to stop, is known as the 2As
and 1 R [32]. With this model, the advice for dental (as
well as medical) practices, is to ask your patient about
smoking, advise your patient about the benefits of stop-
ping, and refer those patients most likely to benefit from
additional help and support to the specialist stop smoking
services. Evaluation of such English services would indi-
cate that 53% of clients were quitters at four weeks[33],
falling to 14.6% at one year [34].
However, not all specialist services have developed ade-
quate referral pathways from primary/secondary dental
care for patients to be streamed towards specialist services,
and there may be patients who have expectations that
smoking cessation advice be delivered to them in the den-
tal setting, as part of the whole care package [35]. Dental
hygienists, by the nature of their training and role within
the dental team, may be the team members best placed to
deliver smoking cessation advice. Barriers such as lack of
funding and training are often cited [36-38]. The training
issues can be dealt with, and a number of initiatives in the
UK are attempting to address this [39,40]. Within the US,
innovative use of new technologies and more interactive
training methods are currently being developed and dis-
seminated [41].
Conclusion
Staff in the dental setting may well have a role in encour-
aging their patients towards quitting and helping them,
either via referral pathways, or, providing the dental staff
are trained and adequately resourced, in delivering the
advice themselves [42]. This study has shown the poten-
tial that trained dental hygienists could have in delivering
smoking cessation advice. However, to add to the defini-
tive knowledge-base, a multi-centred randomised control-
led trial, utilising biochemical verification, with the
smoking cessation advice delivered by trained dental hygi-
enists, would be required to be undertaken.
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